Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
SMALL CAP PRO
Monthly Subscription
for only
|
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
VAT not included
|
|
Pre-Market Last Trade |
Last: $ 0.46 ▲ 0.01 (3.12%) | |
| Company Name | Stock Ticker Symbol | Market | Type | ISIN | Company Description |
|---|---|---|---|---|---|
| Cytrx Corp. (MM) | CYTR | NASDAQ | Common Stock | US2328285091 |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| +0 | +0% | 0.4461 | - | - | - | 0.4461 | 08:43:43 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 0.44 | 0.46 | 0.02 | 4.35% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 3 | 455 | $ 0.4600 | $ 209.3 | 5.57M | 0.36 - 1.00 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 08:43:52 | formt | 300 | $0.46 | USD |
| Industry Sector |
|---|
| Biotechnology |
Cytrx Corp. (MM) Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 73.97M | 165.83M | $ -50.77M | -0.63 | 0.00 | 162.82M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ 0.00 | 0.00% | - | 14.30% |
Cytrx Corp. (MM) News
Confidential Treatment Order (ct Order) Edgar (US Regulatory) • Fri Sep 15, 2017 10:31 AM (5 days ago)
Current Report Filing (8-k) Edgar (US Regulatory) • Wed Sep 13, 2017 5:24 PM (7 days ago)
CytRx Corporation Announces Amendment to Definitive Proxy Statement for Upcoming Special Meeting PR Newswire (US) • Wed Sep 13, 2017 9:00 AM (1 week ago)
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) • Wed Sep 13, 2017 6:01 AM (1 week ago)
Current Report Filing (8-k) Edgar (US Regulatory) • Wed Aug 30, 2017 3:16 PM (3 weeks ago)
CytRx Corporation Files Definitive Proxy Statement for Upcoming Special Meeting PR Newswire (US) • Wed Aug 30, 2017 9:00 AM (3 weeks ago)
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) • Tue Aug 29, 2017 4:55 PM (3 weeks ago)
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CYTR Price Data
| Period † | Open | High | Low | VWAP | Min Vol | Max Vol | Avg. Daily Vol [m] | Change | % |
|---|---|---|---|---|---|---|---|---|---|
| 1 Week | 0.47 | 0.4737 | 0.4028 | 0.4319 | 1M | 4M | 3M | -0.0239 | -5.09% |
| 1 Month | 0.5406 | 0.61 | 0.4028 | 0.5021 | 1M | 6M | 3M | -0.0945 | -17.48% |
| 3 Months | 0.68 | 0.998 | 0.4028 | 0.6852 | 1M | 53M | 5M | -0.2339 | -34.40% |
| 6 Months | 0.42 | 0.998 | 0.3813 | 0.6653 | 516k | 53M | 7M | 0.0261 | 6.21% |
| 1 Year | 0.6 | 0.998 | 0.361 | 0.6355 | 215k | 53M | 4M | -0.1539 | -25.65% |
| 3 Years | 2.74 | 5.42 | 0.361 | 1.2669 | 0 | 53M | 2M | -2.2939 | -83.72% |
| 5 Years | 3.91 | 8.35 | 0.361 | 2.1657 | 0 | 53M | 2M | -3.4639 | -88.59% |
Cytrx Corp. (MM) Description
| CytRx Corporation is a biopharmaceutical research and development company specializing in oncology. Its oncology pipeline includes two programs in clinical development for cancer indications: aldoxorubicin and tamibarotene. |
